<?xml version="1.0" encoding="UTF-8"?>
<ref id="B29-vaccines-08-00174">
 <label>29.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Chan</surname>
    <given-names>K.R.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Saron</surname>
    <given-names>W.A.A.</given-names>
   </name>
   <name>
    <surname>Gan</surname>
    <given-names>E.S.</given-names>
   </name>
   <name>
    <surname>Tan</surname>
    <given-names>H.C.</given-names>
   </name>
   <name>
    <surname>Mok</surname>
    <given-names>D.Z.L.</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>S.L.</given-names>
   </name>
   <name>
    <surname>Lee</surname>
    <given-names>Y.H.</given-names>
   </name>
   <name>
    <surname>Liang</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Wijaya</surname>
    <given-names>L.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Cross-reactive antibodies enhance live attenuated virus infection for increased immunogenicity</article-title>
  <source>Nat. Microbiol.</source>
  <year>2016</year>
  <volume>1</volume>
  <fpage>16164</fpage>
  <pub-id pub-id-type="doi">10.1038/nmicrobiol.2016.164</pub-id>
  <pub-id pub-id-type="pmid">27642668</pub-id>
 </element-citation>
</ref>
